Skip to main content
DCI $95.95 +0.25%
DCI logo

DCI · DONALDSON Co INC

Track DCI — free
$95.95 +0.24 (+0.25%) At close · Aug 14
Market Cap
$11.12B
Shares
115.91M
All earnings calls

Earnings call · FY2026 Q2

DONALDSON Co INC Q2 FY2026 Earnings Call

DONALDSON Co INC Q2 FY2026 Earnings Call

Concluded Feb 26, 2026 Audio replay
Feb 26, 2026 52:22 52 turns
Period
FY2026 Q2
Runtime
52:22
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Donaldson reported record Q2 FY26 sales of $896 million, up 3.0%, with adjusted EPS of $0.83 flat versus the prior-year record, while announcing the Facet acquisition and reaffirming fiscal 2026 guidance for record sales of ~$3.8 billion, all-time-high operating margin of 16.2%, and EPS of $3.97.

FACET acquisition 37 Record sales and full-year outlook 22 Life sciences growth 16 Aftermarket and replacement parts 15 Margin pressure and operational execution 14 Mobile solutions / first-fit truck and off-road 14

Management tone

Positive

Net tone +38 · low hedging

Grounding quotes
  • “we continue to expect a record year for Donaldson now inclusive of record sales of $3.8 billion and sales growth in each of our segments”
  • “our underlying business is robust as evidenced by our high backlogs and continued strong order intake”
  • “Volume deleveraging, concentrated operational inefficiencies related to our production shifts to support higher demand and power generation, and footprint optimization costs negatively impacted gross margin in the quarter”
  • “we face short-term execution challenges in our industrial segment”

Forward guidance

11 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $896.30M +3% YoY
Diluted EPS $0.78 -1.3% YoY
Gross margin 33.4% -1.8 pp YoY
Net income $92.50M -3.5% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Record Q2 sales of $896 million, up 3.0% year over year, with growth across all three segments.
  • Announced acquisition of Facet, the largest in company history, adding ~$110 million in sales with gross and EBITDA margins significantly above the company average and ~70% recurring replacement-part revenue.
  • Life Sciences sales grew 16.2% (16% YoY) driven by robust food and beverage and disk drive growth; Industrial Filtration Solutions sales rose 7.2% on power generation strength.
  • Aftermarket sales up 1.1% with high single-digit growth in the independent channel; sixth consecutive quarter of growth in China, with Q2 sales up 18%.
  • FY26 guidance updated to record sales of ~$3.8 billion, operating margin expanding 50 bps to all-time-high 16.2%, EPS of $3.97 (~8% above prior year), and free cash flow conversion of ~90%.
  • Strong order intake, high backlogs, and announced capacity expansion in the Mexico facility to support power generation demand.

Risks & pressure points

  • Operating margin of 14% declined from 15.2% a year ago due to gross margin pressure from volume deleveraging, operational inefficiencies tied to production shifts, and footprint optimization costs.
  • Aerospace and Defense sales fell 19.4% on project timing, primarily in defense, and management cited ongoing supply chain issues in that business.
  • On-Road first-fit sales decreased 9.2% (down nine percent) on continued declines in global truck production.
  • GAAP net earnings of $92.5 million and GAAP EPS of $0.78 were below prior-year GAAP figures of $95.9 million and $0.79.
  • Facet deal characterized by CFO as more strategic than synergy-driven, expected to be at cost of capital on a cash basis over a five-year horizon, with earnings accretion not expected until year two.
  • Footprint optimization restructuring still ongoing in Q3, with management flagging risk of delays or unexpected problems before fiscal year-end.

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed Feb 26, 2026.

Metric Guided
Adjusted full-year EPS
fiscal 2026
$3.93 – $4.01
Interest expense
fiscal 2026
$26M
Adjusted operating margin
fiscal 2026
16% – 16.4%
Capital expenditures
fiscal 2026
$60M – $75M
Adjusted effective income tax rate
fiscal 2026
22% – 24%
Other income
fiscal 2026
$17M – $19M
Adjusted free cash flow conversion
fiscal 2026
85% – 95%

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Sales
fiscal 2026
$3.8B
Operating margin
fiscal 2026
16.2%
Earnings per share
fiscal 2026
$3.97
Free cash flow conversion
fiscal 2026
at least 90%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Mobile Solutions Segment$556.60M +1.7% YoY
Industrial Solutions Segment$259.70M +2.4% YoY
Life Sciences Segment$80.00M +16.3% YoY

Capital returned

Buybacks · derived
$19.70M
Full-screen source Call document